• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乘客链 miRNA miR-31* 通过靶向 RhoA 调节口腔癌细胞的表型。

Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.

机构信息

Institute of Oral Biology and Department of Dentistry, School of Dentistry, National Yang-Ming University, Taipei, Taiwan.

出版信息

Oral Oncol. 2013 Jan;49(1):27-33. doi: 10.1016/j.oraloncology.2012.07.003. Epub 2012 Jul 31.

DOI:10.1016/j.oraloncology.2012.07.003
PMID:22854067
Abstract

OBJECTIVES

MicroRNAs (miRNAs) are endogenous small non-coding RNAs that negatively regular target gene expression by RNA interference. The processing of the pre-miRNA hairpin generates a miRNA duplex, which consists of a miRNA (guide strand) and a miRNA() (passenger strand). miR-31 is an oncogenic miRNA and is up-regulated in oral squamous cell carcinoma (OSCC). miR-31() shows a high level of conservation across species and, based on this, this study hypothesized that miR-31(*) is a functional miRNA.

MATERIALS AND METHODS

The expression of miR-31 and miR-31* in OSCC tissues and oral cells were analyzed. Functional studies were performed on OSCC cells.

RESULTS

miR-31() is up-regulated in OSCC tissues, but its expression is less abundant than miR-31. miR-31() decreases the proliferation and migration of both SAS and Fadu cells. Furthermore, miR-31() targets the 3'UTR of RhoA and is able to down-regulate RhoA expression. Knockdown of RhoA expression is known to decrease the proliferation and migration of OSCC cells. However, up-regulation of both miR-31 and miR-31() by delivery of pre-mir-31 does still enhance OSCC oncogenicity.

CONCLUSION

miR-31() is a functional miRNA involving in regulating RhoA, and the activity of miR-31()'s activity seems to counteract the functions of miR-31 during OSCC tumorigenesis.

摘要

目的

微小 RNA(miRNA)是内源性的小非编码 RNA,通过 RNA 干扰负调控靶基因表达。前 miRNA 发夹的加工产生 miRNA 双链体,其由 miRNA(引导链)和 miRNA()(过客链)组成。miR-31 是一种致癌 miRNA,在口腔鳞状细胞癌(OSCC)中上调。miR-31()在物种间具有高度保守性,基于此,本研究假设 miR-31(*)是一种功能性 miRNA。

材料和方法

分析 OSCC 组织和口腔细胞中 miR-31 和 miR-31*的表达。在 OSCC 细胞上进行功能研究。

结果

miR-31()在 OSCC 组织中上调,但表达量低于 miR-31。miR-31()降低 SAS 和 Fadu 细胞的增殖和迁移。此外,miR-31()靶向 RhoA 的 3'UTR 并能够下调 RhoA 表达。已知 RhoA 表达的敲低会降低 OSCC 细胞的增殖和迁移。然而,通过递送前 miR-31 上调 miR-31 和 miR-31()仍增强 OSCC 的致癌性。

结论

miR-31()是一种功能性 miRNA,涉及调节 RhoA,miR-31()的活性似乎在 OSCC 肿瘤发生过程中抵消了 miR-31 的功能。

相似文献

1
Passenger strand miRNA miR-31* regulates the phenotypes of oral cancer cells by targeting RhoA.乘客链 miRNA miR-31* 通过靶向 RhoA 调节口腔癌细胞的表型。
Oral Oncol. 2013 Jan;49(1):27-33. doi: 10.1016/j.oraloncology.2012.07.003. Epub 2012 Jul 31.
2
MiRNA-125a-3p is a negative regulator of the RhoA-actomyosin pathway in A549 cells.miRNA-125a-3p 是 A549 细胞中 RhoA-肌动球蛋白通路的负调节剂。
Int J Oncol. 2013 May;42(5):1734-42. doi: 10.3892/ijo.2013.1861. Epub 2013 Mar 21.
3
miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.miR-370 调节胰岛素受体底物 1 的表达并抑制口腔癌的肿瘤表型。
Oral Dis. 2013 Sep;19(6):611-9. doi: 10.1111/odi.12046. Epub 2012 Dec 12.
4
miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.miR-185 靶向 RhoA 和 Cdc42 的表达并抑制人结直肠细胞的增殖潜能。
Cancer Lett. 2011 Feb 28;301(2):151-60. doi: 10.1016/j.canlet.2010.11.009. Epub 2010 Dec 24.
5
Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.miR-187的上调通过靶向BARX2肿瘤抑制因子来调节口腔癌的进展。
Oncotarget. 2016 Sep 20;7(38):61355-61365. doi: 10.18632/oncotarget.11349.
6
Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.结缔组织生长因子通过激活 miR-504/FOXP1 信号调节口腔鳞状细胞癌侵袭。
Oncogene. 2012 May 10;31(19):2401-11. doi: 10.1038/onc.2011.423. Epub 2011 Sep 19.
7
miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.miR-181a 通过下调 K-ras 对口腔鳞状细胞癌细胞表现出肿瘤抑制作用。
Biochem Biophys Res Commun. 2011 Jan 28;404(4):896-902. doi: 10.1016/j.bbrc.2010.12.055. Epub 2010 Dec 15.
8
miR-221 and miR-222 expression increased the growth and tumorigenesis of oral carcinoma cells.miR-221 和 miR-222 的表达促进了口腔癌细胞的生长和肿瘤发生。
J Oral Pathol Med. 2011 Aug;40(7):560-6. doi: 10.1111/j.1600-0714.2010.01005.x. Epub 2011 Jan 13.
9
miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.口腔癌中 miR-24 的上调:临床和体外分析的正相关关系。
Oral Oncol. 2010 Mar;46(3):204-8. doi: 10.1016/j.oraloncology.2009.12.005. Epub 2010 Feb 6.
10
MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.微小RNA-9通过Wnt/β-连环蛋白信号通路抑制趋化因子受体4(CXCR4)的表达,从而抑制口腔鳞状细胞癌细胞的增殖。
Oncogene. 2014 Oct 16;33(42):5017-27. doi: 10.1038/onc.2013.448. Epub 2013 Oct 21.

引用本文的文献

1
The antihyperlipidemic drug potassium piperonate impairs the migration and tumorigenesis of breast cancer cells the upregulation of miR-31.抗高血脂药物胡椒酸钾通过上调miR-31来损害乳腺癌细胞的迁移和肿瘤发生。
Front Oncol. 2022 Oct 13;12:828160. doi: 10.3389/fonc.2022.828160. eCollection 2022.
2
MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma.微小RNA-31:口腔鳞状细胞癌中的关键致癌因子。
Cell Death Discov. 2022 Mar 29;8(1):140. doi: 10.1038/s41420-022-00948-z.
3
MicroRNA‑198 suppresses tumour growth and metastasis in oral squamous cell carcinoma by targeting CDK4.
MicroRNA-198 通过靶向 CDK4 抑制口腔鳞状细胞癌的肿瘤生长和转移。
Int J Oncol. 2021 Jul;59(1). doi: 10.3892/ijo.2021.5219. Epub 2021 May 13.
4
Emerging roles and mechanisms of microRNA‑222‑3p in human cancer (Review).微小 RNA-222-3p 在人类癌症中的新兴作用和机制(综述)。
Int J Oncol. 2021 May;58(5). doi: 10.3892/ijo.2021.5200. Epub 2021 Mar 24.
5
Effects of isoprenylcysteine carboxyl methyltransferase silencing on the proliferation and apoptosis of tongue squamous cell carcinoma.异戊烯半胱氨酸羧基甲基转移酶沉默对舌鳞癌细胞增殖和凋亡的影响。
Hua Xi Kou Qiang Yi Xue Za Zhi. 2021 Feb 1;39(1):64-73. doi: 10.7518/hxkq.2021.01.010.
6
Premature MicroRNA-Based Therapeutic: A "One-Two Punch" against Cancers.基于微小RNA的早期治疗:对抗癌症的“双重打击”。
Cancers (Basel). 2020 Dec 18;12(12):3831. doi: 10.3390/cancers12123831.
7
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival.泛癌症分析揭示了调控肿瘤发生和患者生存的 miRNA 双链的协同作用。
Nat Commun. 2020 Feb 20;11(1):968. doi: 10.1038/s41467-020-14713-2.
8
MicroRNAs as Potential Biomarkers in Atherosclerosis.微小 RNA 作为动脉粥样硬化的潜在生物标志物。
Int J Mol Sci. 2019 Nov 7;20(22):5547. doi: 10.3390/ijms20225547.
9
miR‑148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑G expression.miR-148a 通过调控 HLA-G 的表达来调节口腔鳞状细胞癌细胞的活力、迁移和侵袭。
Mol Med Rep. 2019 Jul;20(1):795-801. doi: 10.3892/mmr.2019.10280. Epub 2019 May 22.
10
Substantial Dysregulation of miRNA Passenger Strands Underlies the Vascular Response to Injury.大量 miRNA 过客链的失调是损伤后血管反应的基础。
Cells. 2019 Jan 23;8(2):83. doi: 10.3390/cells8020083.